Quality of life development during initial hemodialysis therapy and association with loss of residual renal function.
Health related quality of life (HRQOL) is markedly reduced in hemodialysis patients compared to the general population. We investigated the course of self-reported HRQOL over time and the association with selected factors, focusing on changes in glomerular filtration rate (GFR).



Eighty-two newly started hemodialysis patients from the SAFIR cohort filled out the Kidney Disease Quality of Life Short Form Version 1.3 (KDQOL-SFTM) questionnaire at baseline, 6 and 12 months. The SAFIR study was a randomized, placebo-controlled, double-blind intervention study, examining the effects of the angiotensin II receptor blocker irbesartan. HRQOL was a secondary outcome measure. Main inclusion criteria: Dialysis vintage <1 year, left ventricular ejection fraction >30% and urinary output >300 mL/day. GFR was measured with mean creatinine and urea clearance from 24-hour urine collections at baseline, 6 and 12 months.



Irbesartan treatment did not affect HRQOL. Patients were pooled into one group for further analyses. Decline in GFR correlated significantly with decreasing HRQOL over time. HRQOL was stable over time, with a slight nonsignificant tendency toward improved HRQOL. The largest HRQOL-differences (positive values equal improved HRQOL) observed during the 12 month study period were (mean[95% confidence interval]): Burden of kidney disease:6.4[-2.2;15.0], Role limitations-physical:12.7[-2.1;27.5], and Role limitations-emotional:9.7[-5.2;24.6]. Comorbidity, especially diabetes, hospital admissions, female gender, and age were strongly associated with lower HRQOL in cross sectional analysis.



Preservation of residual renal function seems to be important for HRQOL. In newly started HD patients, HRQOL showed little change after 12 months. HRQOL was negatively affected by comorbidity, especially diabetes, hospital admissions, female gender, and age.
Department of Renal Medicine, Aarhus University Hospital, Denmark.
Christina G
0000-0002-4355-3081
CG
Poulsen
Department of Renal Medicine, Aarhus University Hospital, Denmark.
Krista D
KD
Kjaergaard
Department of Renal Medicine, Aarhus University Hospital, Denmark.
Christian D
CD
Peters
Department of Renal Medicine, Aarhus University Hospital, Denmark.|Institute of Clinical Medicine, Aarhus University, Denmark.
Bente
B
Jespersen
Department of Renal Medicine, Aarhus University Hospital, Denmark.|Institute of Clinical Medicine, Aarhus University, Denmark.
Jens D
JD
Jensen
D005260:Female; D005919:Glomerular Filtration Rate / Q000502:physiology*; D006801:Humans; D007674:Kidney Diseases / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis / Q000009:adverse effects / Q000379:methods*; D057566:Self Report
Kidney Disease Quality of Life Short Form; Quality of life; glomerular filtration rate; hemodialysis; residual renal function